Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
22-26 September, 2024
SPE Annual TechnicalSPE Annual Technical
Not Confirmed
Not Confirmed
23-25 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
22-26 September, 2024
SPE Annual TechnicalSPE Annual Technical
Industry Trade Show
Not Confirmed
23-25 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/bms-bayer-takeda-pfizer-downsize-to-combat-cost-pressures-meet-restructuring-plans
17 Sep 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/jj-talc-appeal-upends-260m-award-oregon-woman-mesothelioma
17 Sep 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/research/trispecific-antibody-ichnos-glenmark-innovation-beats-janssens-tecvayli-treating-multiple
16 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/15/2946278/0/en/New-data-from-TAR-200-Phase-2b-SunRISe-1-study-show-84-percent-complete-response-rate-in-patients-with-high-risk-non-muscle-invasive-bladder-cancer.html
16 Sep 2024
// #N/A
https://pharmaphorum.com/news/esmo-jj-cues-phase-3-rybrevant-colorectal-cancer
16 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neoadjuvant-tar-200-plus-cetrelimab-nearly-doubles-the-pathological-complete-response-rate-compared-to-cetrelimab-alone-in-patients-with-muscle-invasive-bladder-cancer-302248459.html
14 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/14/2946235/0/en/RYBREVANT-amivantamab-plus-chemotherapy-shows-positive-overall-survival-trend-versus-chemotherapy-in-patients-with-previously-treated-EGFR-mutated-lung-cancer.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Johnson & Johnson is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Nicotine bulk with DMF offered by Johnson & Johnson
Find a price of Naloxone Hydrochloride bulk offered by Johnson & Johnson
LOOKING FOR A SUPPLIER?